Is fish oil still worth taking?

Fish oil sits in more medicine cabinets than almost any other supplement, a golden capsule most people started taking on the general belief that it is "good for your heart." For a long time that belief rested on reasonable evidence. Over the last several years, some of the largest cardiovascular trials ever run have complicated it considerably, and the honest answer to whether it is worth taking now depends heavily on who you are and what dose you mean.

What the biggest trial in healthy people found

The VITAL trial, published in the New England Journal of Medicine, is the clearest test of what a typical over-the-counter fish oil dose does for an average healthy adult. Researchers gave 25,871 people 1 gram a day of marine omega-3s and followed them for more than five years, then compared their rates of heart attack, stroke and cardiovascular death against a placebo group. The result was a hazard ratio of 0.97, meaning essentially no difference, and the finding was not statistically significant. The trial's own conclusion was direct: omega-3 supplementation was not effective at preventing major cardiovascular events in this broad, largely healthy population.

That is not a fluke result from one study. A 2020 Cochrane review, the closest thing medicine has to a final word on a question, pooled 79 randomized trials and more than 112,000 participants and reached a similar conclusion. Long-chain omega-3 supplements showed little or no effect on heart disease, stroke or death from any cause; the death rate was 8.8% in the omega-3 group versus 9.0% in the control group, a gap small enough to be noise. Dr. Lee Hooper, the review's lead author, said the findings go against the popular belief that fish oil protects the heart, and that the evidence is good enough to be confident in that conclusion.

The trial that complicates the story

Here is where fish oil's reputation gets genuinely more interesting rather than simply debunked. The REDUCE-IT trial tested a prescription drug, icosapent ethyl, sold as Vascepa, in 8,179 people who already had heart disease or diabetes plus other risk factors and elevated triglycerides despite taking a statin. At 4 grams a day of purified EPA, several times a standard supplement dose, the drug cut the combined rate of cardiovascular events by about 25% and cardiovascular death by roughly 20%.

That is a real, meaningful result, but it comes with an asterisk worth knowing. Dr. Steven Nissen, chief academic officer at Cleveland Clinic, has pointed out that REDUCE-IT used a mineral oil placebo, which some researchers argue may have modestly worsened the comparison group's cholesterol markers and inflated the apparent benefit. A separate high-dose trial, STRENGTH, tested a different EPA-plus-DHA formula at the same 4 grams a day against a corn oil placebo that Nissen calls "truly neutral," and found no cardiovascular benefit at all. STRENGTH was stopped early for futility, and it also turned up a real safety signal: atrial fibrillation occurred in 2.2% of the omega-3 group versus 1.3% on placebo, a roughly 70% relative increase.

Put together, the honest reading is that a specific prescription drug, at a specific high dose, helped a specific high-risk group in one major trial, while a similarly high dose of a different formula helped nobody in another. That is not the same claim as "fish oil protects your heart."

Where fish oil's benefit is real and established

None of this means fish oil does nothing. Lowering triglycerides is its most solid, least disputed effect, well established enough that the FDA has approved prescription-strength omega-3 specifically for that purpose in people with elevated levels. The American Heart Association's position, summarized in a science advisory, reflects this nuance directly: fish oil is considered reasonable for people with existing coronary disease after a heart attack, and for people with heart failure with reduced ejection fraction, where a major Italian trial found a real reduction in death. For preventing a first cardiovascular event in an otherwise healthy person, the advisory says no recommendation can currently be made, because the trial evidence simply is not there.

What that means for the bottle in your cabinet

If you are healthy and take a standard low-dose fish oil supplement hoping it will prevent a future heart attack, the largest and most rigorous trials available do not support that specific expectation, in the same way the research keeps narrowing what an ordinary multivitamin can promise, or whether you actually need a vitamin D supplement at all. If you already have heart disease, heart failure, or high triglycerides, the picture is different, and a real conversation with a cardiologist about prescription-strength options may be worth having.

Our take

Fish oil is not a scam, but it is not the blanket heart-protector its reputation suggests either. The best studies in healthy people show little to no benefit at typical doses, the one strong positive trial involved a high-dose prescription drug in a high-risk group with a debated placebo, and a comparable high-dose trial found no benefit at all. Its clearest, least controversial job is lowering triglycerides. Everything past that deserves a conversation with your own doctor, not a default bottle on the supplement aisle.

This is general information, not medical advice. Talk to a clinician before changing anything, especially if you are pregnant, nursing, or managing a condition.